Bioneer Corporation (KOSDAQ: A064550)
Health Care · Biotechnology · KR
₩8,460.00
-1.28% today · -37.1% 1Y
Bioneer Corporation (KOSDAQ: A064550) operates in the Biotechnology industry within the Health Care sector. The company is valued at $162.42M.
Over the last twelve months the share price has lost 37.1%, trading between 5.47K and 15.64K.
Tweenvest scores Bioneer Corporation across four factors: quality 75/100, value 73/100. Its strongest factor is quality.
A064550 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $162.42M
- Revenue (TTM)
- $223.35M
- P/E
- —
- EPS
- -258.54
- Dividend yield
- —
- Beta (5Y)
- 0.35
- 52-week high
- ₩15,640.00
- 52-week low
- ₩5,470.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.81M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $165.92M | ₩7,940.00 | +1.79% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $163.36M | $15.00 | -3.16% |
| GC Cell CorporationKOSDAQ: A144510 | $163.20M | ₩14,600.00 | +0.14% |
| Protara Therapeutics, Inc.NasdaqGM: TARA | $162.81M | $2.77 | +0.54% |
| Nkarta, Inc.NasdaqGS: NKTX | $161.16M | $2.17 | -3.56% |
| curacle co.,ltd.KOSDAQ: A365270 | $161.02M | ₩9,770.00 | -4.22% |
| Pacific Edge LimitedNZSE: PEB | $160.23M | NZ$0.23 | -8.00% |
| Satellos Bioscience Inc.TSX: MSCL | $159.25M | CA$10.71 | -10.82% |
Figures last refreshed Oct 11, 2026.